{"schema_version":"1","generated_at":"2026-10-28T12:48:03.428Z","data_as_of":null,"url":"https://www.findmykol.com/kol/fahmeedah-kamal","json_url":"https://www.findmykol.com/kol/fahmeedah-kamal/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"fahmeedah-kamal","name":"Fahmeedah Kamal","credential":"MD","specialty":"Nephrology","specialty_raw":"Nephrology","therapeutic_area":"Nephrology","therapeutic_areas":["Nephrology"],"institution":"Stanford Medicine","institution_url":"https://www.findmykol.com/institution/stanford-university-school-of-medicine","city":"Stanford","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1154579969","orcid":"0009-0006-1598-9140","openalex":"A5039415324"},"summary":"Fahmeedah Kamal is a Nephrology physician affiliated with Stanford Medicine. OpenAlex indexes 13 publications with 267 citations (h-index 4); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Nephrology"]},"scholarship":{"works_count":13,"cited_by_count":267,"h_index":4,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03949855","title":"Belimumab With Rituximab for Primary Membranous Nephropathy","phase":"PHASE2","status":"RECRUITING","role":"Site investigator","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","source_url":"https://clinicaltrials.gov/study/NCT03949855","trial_url":"https://www.findmykol.com/trial/NCT03949855"}],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":12,"shown":3,"withheld":9,"rows":[{"payer":"Apellis Pharmaceuticals, Inc.","program_year":2025,"amount_usd":141.38,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154579969"},{"payer":"Amgen Inc.","program_year":2025,"amount_usd":28.99,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154579969"},{"payer":"Calliditas Therapeutics US Inc.","program_year":2025,"amount_usd":23.29,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154579969"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1154579969","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Cardiovascular","share_pct":61.3,"classes_total":5,"classes":[{"class":"Angiotensin receptor blocker (ARB)","setting":"prescribed","share_pct":24.1,"drugs":[{"name":"Losartan Potassium","share_pct":62.6},{"name":"Olmesartan Medoxomil","share_pct":37.4}],"max_beneficiaries":null},{"class":"Calcium channel blocker","setting":"prescribed","share_pct":11.7,"drugs":[{"name":"Amlodipine Besylate","share_pct":100}],"max_beneficiaries":16}]},{"area":"Blood & clotting","share_pct":17.5,"classes_total":2,"classes":[{"class":"Erythropoiesis-stimulating Agent","setting":"prescribed","share_pct":11.7,"drugs":[{"name":"Procrit","share_pct":70.5},{"name":"Retacrit","share_pct":29.5}],"max_beneficiaries":null},{"class":"Solutions for parenteral nutrition","setting":"prescribed","share_pct":5.8,"drugs":[{"name":"Calcium Acetate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Other","share_pct":9,"classes_total":2,"classes":[{"class":"Phosphate Binder","setting":"prescribed","share_pct":5,"drugs":[{"name":"Sevelamer Carbonate","share_pct":100}],"max_beneficiaries":null},{"class":"Drugs for treatment of hyperkalemia and hyperphosphatemia","setting":"prescribed","share_pct":4,"drugs":[{"name":"Lokelma","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":36.7,"facility_pct":63.3},"source":"medicare"},"publications":{"total":8,"shown":5,"withheld":3,"matched_by":"OpenAlex author record","recent":[{"title":"Current trial landscape of IgA nephropathy therapy","year":2026,"journal":"Med","source_url":"https://doi.org/10.1016/j.medj.2025.100940","status":"verified"},{"title":"How should we best manage the consequences of nephron loss in IgAN?","year":2025,"journal":"Nephrology Dialysis Transplantation","source_url":"https://doi.org/10.1093/ndt/gfaf225","status":"verified"},{"title":"Kappa-Restricted IgA Nephropathy Treated Successfully With Targeted-Release Budesonide","year":2025,"journal":"Kidney International Reports","source_url":"https://doi.org/10.1016/j.ekir.2025.11.033","status":"verified"},{"title":"Current Biomarkers of IgA Nephropathy","year":2024,"journal":"Seminars in Nephrology","source_url":"https://doi.org/10.1016/j.semnephrol.2025.151572","status":"verified"},{"title":"Considering the Treatment of IgA Nephropathy","year":2023,"journal":"Clinical Journal of the American Society of Nephrology","source_url":"https://doi.org/10.2215/cjn.0000000000000261","status":"verified"}],"source":"works"},"contact":{"address_1":"300 PASTEUR DR","city":"Stanford","state":"CA","zip":"943052200","phone":"650-723-4000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1154579969","source":"identity"},"similar":[{"name":"Jeffrey Teuteberg","slug":"jeffrey-teuteberg","institution":"Stanford Medicine","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/jeffrey-teuteberg","json_url":"https://www.findmykol.com/kol/jeffrey-teuteberg/profile.json"},{"name":"Charles Debattista","slug":"charles-debattista","institution":"Stanford Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/charles-debattista","json_url":"https://www.findmykol.com/kol/charles-debattista/profile.json"},{"name":"Michael Amylon","slug":"michael-amylon","institution":"Stanford Medicine","specialty":"Pediatric Hematology-Oncology","url":"https://www.findmykol.com/kol/michael-amylon","json_url":"https://www.findmykol.com/kol/michael-amylon/profile.json"},{"name":"Kimberly Dequattro","slug":"kimberly-dequattro","institution":"Stanford Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/kimberly-dequattro","json_url":"https://www.findmykol.com/kol/kimberly-dequattro/profile.json"},{"name":"Andrew Levey","slug":"andrew-levey","institution":"Tufts Medical Center","specialty":"Nephrology","url":"https://www.findmykol.com/kol/andrew-levey","json_url":"https://www.findmykol.com/kol/andrew-levey/profile.json"},{"name":"Bertram Kasiske","slug":"bertram-kasiske","institution":"Hennepin Healthcare","specialty":"Nephrology","url":"https://www.findmykol.com/kol/bertram-kasiske","json_url":"https://www.findmykol.com/kol/bertram-kasiske/profile.json"},{"name":"Garabed Eknoyan","slug":"garabed-eknoyan","institution":"Baylor College of Medicine","specialty":"Nephrology","url":"https://www.findmykol.com/kol/garabed-eknoyan","json_url":"https://www.findmykol.com/kol/garabed-eknoyan/profile.json"},{"name":"Lawrence Hunsicker","slug":"lawrence-hunsicker","institution":"University of Iowa","specialty":"Nephrology","url":"https://www.findmykol.com/kol/lawrence-hunsicker","json_url":"https://www.findmykol.com/kol/lawrence-hunsicker/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":9,"publications":3}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-04-18","provider_certified":"2024-04-18","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}